Secondly, sample size within some patient groups (e.g., liver allograft recipient and IBD with anti-TNF treatment group) was not robust enough to conclude with confidence that increased risk of HEV infection is associated with an underlying medical condition. The gene discussed is TNF; the disease is inflammatory bowel disease.